drugset / Trial / NCT05153304
Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if it is possible to make and safely administer a 'personalized' cancer vaccine for people diagnosed with an upper gastrointestinal tract cancer.
Timeline
- Start
- 2024-06
- Primary completion
- 2026-06
- Completion
- 2027-06
Outcome
Outcome not reported
Stopped (Business): “funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nivolumab | Monoclonal antibody | 480 mg | Intravenous |
| Subject | personalized vaccine | Vaccine | — | — |